NCT05617885 2026-02-27Neo-DAB: Darolutamide and Abemaciclib in Prostate CancerDana-Farber Cancer InstitutePhase 1 Active not recruiting9 enrolled
NCT02023463 2025-11-25Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate CancerThomas Jefferson UniversityPhase 1 Active not recruiting25 enrolled